Showing 19,501 - 19,520 results of 32,095 for search '(( 5 ((fold decrease) OR (point decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 19501

    Extraction time and mustard concentration for extraction of aquatic oligochaetes by using wet funnel by Satoshi Kaneda (571209)

    Published 2025
    “…In Exp. S1.2, a fresh volume of approximately 100 cc of stock soil which had been collected from the same station was used because the original stock soil sample had already been depleted at that point. …”
  2. 19502

    Table_3_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  3. 19503

    Propagation of GABA-induced hyperpolarization at the axon regulates AP generation. by Yang Xia (104600)

    Published 2014
    “…Right, group data showing a decrease in the mean frequency of APs after GABA iontophoresis at the axon trunk. **, P<0.01, paired t-test. …”
  4. 19504

    The effect of (+)-pentazocine and H<sub>2</sub>O<sub>2</sub> on ONHAs viability. by Jing Zhao (21160)

    Published 2017
    “…At the highest concentration of PTZ (50μM), there was a trend toward decrease in viability that was not significant. …”
  5. 19505

    Table_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  6. 19506

    Table_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  7. 19507

    Image_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  8. 19508

    Image_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  9. 19509

    Table_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  10. 19510

    Table_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  11. 19511

    Table_3_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  12. 19512

    Image_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  13. 19513

    Image_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF by Lorenzo Di Cesare Mannelli (600627)

    Published 2018
    “…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
  14. 19514

    Metabolic and Behavioral Compensations in Response to Caloric Restriction: Implications for the Maintenance of Weight Loss by Leanne M. Redman (170737)

    Published 2009
    “…</p><h3>Conclusions</h3><p>For the first time we show that in free-living conditions, CR results in a metabolic adaptation and a behavioral adaptation with decreased physical activity levels. …”
  15. 19515

    Piwi dissociates from mitotic nuage at the central spindle in a <i>klp10A</i>-dependent manner. by Zsolt G. Venkei (8575353)

    Published 2020
    “…Open arrowheads (D) point to a Piwi-positive nuage particle, sliding along and later releasing the MT bundle, without decreasing GFP-Piwi signal. …”
  16. 19516

    52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B by Teerha Piratvisuth (279131)

    Published 2013
    “…<div><h3>Background and Aims</h3><p>The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. …”
  17. 19517

    Efficacy of combined interventions including preventative NPIs (e.g., masking, distancing, lockdowns) and testing and isolation. by Emily Howerton (10988025)

    Published 2021
    “…Moves can maintain NPI intensity with a less sensitive test (thick arrows), decrease NPI intensity with the same test (medium arrows), and decrease NPI intensity with a less sensitive test (light arrows). …”
  18. 19518

    Supplementary file 1_Persistent burden and health inequalities of disease in women of childbearing age attributable to Intimate Partner Violence, 1990–2021.docx by Yingda Song (15410321)

    Published 2025
    “…The IPV-attributable ASMR decreased from 2.61 per 100,000 population in 1990 (95% UI: 1.73 to 3.71) to 2.26 per 100,000 population in 2021 (95% UI: 1.45 to 3.21), with AAPC of -0.46 (95% CI: -0.60 to -0.33). …”
  19. 19519

    Neurons from Kidins220<sup>−/−</sup> mice showed normal post-tetanic potentiation and synaptic depression of evoked EPSCs. by Joachim Scholz-Starke (324807)

    Published 2013
    “…The increase of the EPSC1 amplitude (arrows) is connected to a decrease of the paired-pulse ratio. Holding potential −86 mV. …”
  20. 19520

    Some primate species encode a CD4 that functions as an entry receptor for an early isolate of HIV-1. by Cody J. Warren (563898)

    Published 2019
    “…Values above error bars represent fold decrease in viral entry relative to human CD4, only indicated for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <i>P</i> < 0.05). …”